Item 5.01 Changes in Control of Registrant.
On or about August 14, 2020, Kim Halvorson was appointed CEO, CFO and sole
Director and of the issuer (the "Company" or the "Registrant") and, pursuant to
an employment agreement under which Ms. Halvorson agreed to cause the Company to
become current on OTC Markets, was granted control of the Company via Preferred
Shares. This change in control and the authorization for the Preferred Shares
was filed with the Secretary of State in Florida, the Company's domicile state,
on September 22, 2020.
On April 13, 2021, an Amendment to the Articles of Incorporation was filed with
the Secretary of State in Florida, the Company's domicile state, amending the
structure of the Company's Preferred Shares and issuing new Preferred shares to
Ms. Halvorson.
No new Common Shares were authorized or issued in these transactions.
As a result, Ms. Halvorson owns a majority of the Voting Interests in the
Company. This has been verified by the Transfer Agent.
The Company is currently Pink Current on OTC Markets. Additionally, the Company
has hired securities counsel and is working with OTC Markets to get the Caveat
Emptor designation removed from its profile.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective on or about August 14, 2020, Kim Halvorson became the sole Officer and
Director of the Company. All other Officers and Directors resigned. There are no
agreements, arrangements or understandings among or between current and former
Officers and Directors with respect to any matter relating to the Company.
Ms. Halvorson is a seasoned Business Development and Marketing professional that
thrives in new and innovative environments. Over her 25 year career, she has
exposure to all spectrums of the business continuum. She started in medical
practice management software systems and then moved to holding strategic roles
in large corporate structures such as Dell Computer Corporation and successful
startups like SCI Solutions (complex hospital scheduling). Thereafter, she went
on to be a founding partner at Triage VC, where she continues to work with
diverse ventures, leveraging her vast industry connections. Her expertise has
helped various companies in the areas of investment banking, marketing and
business development, with an emphasis on managing reporting of public companies
involved with SEC, FINRA and OTC markets.
On or about December 17, 2020, Don Zeppenfeld was elected to the Company's Board
of Directors. As an Independent Board Member, his roles will be Corporate
Oversight and growing the Company's Business Development prospects. Mr.
Zeppenfeld recently retired from Quest Diagnostics Inc., where he was
responsible for building their national accounts Quantum Enterprise Content
Solutions division. Mr. Zeppenfeld is also a seasoned turnaround executive. He
was on the founding team of Scheduling.com -- now SCI Solutions -- where he
helped build it from an incubator organization to a well-established profitable
organization.
On or about December 29, 2020, Robert Clegg was elected to the Company's Board
of Directors. As an Independent Board Member, his roles will be Corporate
Oversight and growing the Company's Business Development prospects. Mr. Clegg is
an established award-winning entrepreneur with a proven track record of
successful ventures at every stage in the business spectrum, Robert Clegg has
been a leader in strategic planning, innovation and development for various
companies for over 25 years. He has successfully taken 5 startups from
conception through development, funding and operation - Instructional Sports
Software, Digital Impact, Career DNA, iStadium, and Tabula Digita (now
DimensionU.com) - and is a seasoned executive with expertise in product
development and agile methodologies.
--------------------------------------------------------------------------------
2
--------------------------------------------------------------------------------
Item 8.01 Other Events
Neither the Company nor any of its Officers and Directors have any relationship,
agreement or involvement with certain individuals or entities that have recently
been indicted for manipulating the Company and/or its stock for personal gain.
None of these individuals or entities have had or currently have any control of
or management of the Company.
The issuer Bell Buckle Holdings Inc. is a non-reporting company. This filing is
being made under certain exemptions as a volunteer filer. The issuer is current
on its filings with OTC Markets.
Management is working in good faith with OTC Markets to get the Caveat Emptor
designation removed from its profile.
Additionally, the Company has a business strategy and model going forward, has
realized revenue thereunder and has contractual agreements in place to further
create value for its shareholders and stakeholders.
--------------------------------------------------------------------------------
3
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
BELL BUCKLE HOLDINGS, INC. 
